JPMorgan has raised its price target on Eli Lilly (LLY.N) to $1,500 from $1,400, according to a Sept. 28 market brief carried by BlockBeats. The item was published as a short 7x24 news update and did not include the bank’s rationale for the revision. No additional details on timing beyond the publication date, valuation framework, or analyst comments were provided in the source. The update only stated that JPMorgan adjusted its target for the stock upward by $100.
JPMorgan has raised its price target on Eli Lilly (LLY.N) to $1,500 from $1,400, according to a Sept. 28 update published by BlockBeats.
This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan. Disclaimer:
The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.
Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.
